{"transactions":[{"id":4636984,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-10-07T20:09:53.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17142,"price":5,"value":85710.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":13683,"source":{"system":"sec-edgar","filing":"0001447028-26-000059","document":"wk-form4_1791403791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000059/wk-form4_1791403791.xml","form_type":"4"}},{"id":4625861,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 78,800 shares, was fully vested and exercisable as of the June 8, 2026 grant date."}],"balance_after":0,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625860,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":52533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 157,600 shares, vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd and 3rd anniversaries of the August 4, 2025 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":105067,"derivative":{"exercise_price":3.34,"expiration_date":"2035-08-04","underlying":"Common Shares","underlying_shares":52533},"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625859,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":100508,"price":5.07,"value":509575.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 100,508 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":30825,"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625858,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":78800,"price":4.24,"value":334112.0,"ownership":{"direct":true},"balance_after":131333,"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":4625857,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:17.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":52533,"price":3.34,"value":175460.22,"ownership":{"direct":true},"balance_after":52533,"source":{"system":"sec-edgar","filing":"0001447028-26-000051","document":"wk-form4_1790209875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000051/wk-form4_1790209875.xml","form_type":"4"}},{"id":743285,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:05:32.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":78800,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000040","document":"wk-form4_1781121928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702826000040/wk-form4_1781121928.xml","form_type":"4"}},{"id":766188,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-05-22T20:10:59.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest in full on the anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.42,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001683168-26-004255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000168316826004255/ownership.xml","form_type":"4"}},{"id":1073192,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-06T20:08:29.000Z","date":"2025-08-04","kind":"grant","planned":false,"acquired":true,"shares":157600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":157600,"derivative":{"exercise_price":3.34,"expiration_date":"2035-08-04","underlying":"Common Shares","underlying_shares":157600},"source":{"system":"sec-edgar","filing":"0001447028-25-000120","document":"wk-form4_1754510902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000144702825000120/wk-form4_1754510902.xml","form_type":"4"}},{"id":1135545,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-23T20:05:33.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest in full on the anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":10.1,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001683168-25-003993","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000168316825003993/ownership.xml","form_type":"4"}},{"id":1433865,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2024-08-14T23:25:49.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"30,000 stock options granted upon the effectiveness of the registration statement for the issuer's initial public offering on August 12, 2024, which vest in three equal installments on the first, second, and third anniversary of the grant date, subject to the reporting person's continued service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-089791","document":"tm2421559-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000110465924089791/tm2421559-6_4seq1.xml","form_type":"4"}},{"id":1983976,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2023-03-01T16:25:21.000Z","date":"2023-02-25","kind":"grant","acquired":true,"shares":2252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The closing price for the Issuer's common stock on the Nasdaq Global Market on February 27, 2023, the first trading day after the grant of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest monthly and become exercisable in equal monthly installments beginning on March 12, 2023, and ending on July 12, 2023, with the final installment adjusted as necessary to avoid any fractional shares in any installment."}],"balance_after":2252,"derivative":{"exercise_price":2.2092,"expiration_date":"2033-02-24","underlying":"Common Stock","underlying_shares":2252},"source":{"system":"sec-edgar","filing":"0001474506-23-000074","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000147450623000074/primary_doc.xml","form_type":"4"}},{"id":2337902,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-03-11T21:05:21.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable with respect to 25% of the underlying shares on March 9, 2023 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 9, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":10.34,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-010691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000089924322010691/doc4.xml","form_type":"4"}},{"id":2618113,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":30337,"kind":"person","name":"Sawhney Roger","position":1,"cik":"0001858748","reported_name":"Sawhney Roger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-03T21:16:19.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":2941,"price":17,"value":49997.0,"ownership":{"direct":true},"balance_after":2941,"source":{"system":"sec-edgar","filing":"0000899243-21-031305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858748/000089924321031305/doc4.xml","form_type":"4"}}]}